Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 31. oktober 2023 kl. 15:30 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Michael Engsig | – | Kjøp | 9 850 | 17,1 NOK | 31. oktober 2023 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- Attachment 231031.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, October 31, 2023 - Primary insider Michael Engsig, Chief Executive Officer of Nykode Therapeutics ASA, has today acquired 9,850 shares in Nykode Therapeutics ASA at a price of NOK 17.10 per share.
Please see further details in the attached document.